- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 93.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 97.33M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 36.72M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $770.22K |
| Capex | Q1 2026 · Mar 31, 2026 | $3.16K |
| Capex | Q1 2026 · Mar 31, 2025 | $75.41K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.42M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.58M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $6.37M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $17.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $35.65M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.51M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $12M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $44.51M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $40.88M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $48.71M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $43.65M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $38.84M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $22.21M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $68.21M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $79.3M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.14 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.14 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.44M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $3.71M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $610.8K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $654.05K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$17.7M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.16M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.37M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$4.11M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $5.57M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $3.16M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $8.93M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $4.28M |
| Revenue | Q1 2026 · Mar 31, 2026 | $14.5M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $7.44M |